Parkside Financial Bank & Trust’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
AIM
Parkside Financial Bank & Trust's RDY Position: Q2 2026 in Review
Parkside Financial Bank & Trust reduced its Dr. Reddy's Laboratories (RDY) stake by 23% in Q2 2026, selling an estimated $3.51K and leaving 866 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1580.
Parkside Financial Bank & Trust first reported a position in RDY in Q1 2025 and has held it in 6 quarters since. The position peaked at $15.8K in Q4 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- Parkside Financial Bank & Trust held 866 shares of Dr. Reddy's Laboratories worth $12.5K as of Q2 2026.
- Parkside Financial Bank & Trust sold 260 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $3.51K.
- Dr. Reddy's Laboratories made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1580 holding.
- Parkside Financial Bank & Trust first reported a position in Dr. Reddy's Laboratories in Q1 2025 and has held it in 6 quarters since.
- Parkside Financial Bank & Trust's Dr. Reddy's Laboratories position peaked at $15.8K in Q4 2025.
- 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.